ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Free Cash Flow

Operating cash flow minus capital expenditures: cash available for debt repayment, dividends, and buybacks.

No reported Free Cash Flow figures are available to summarize.

Free Cash Flow history

Currency unavailable · from the cash flow

No Free Cash Flow data reported for this period type.

Free Cash Flow vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Free Cash Flow for ADRX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
WVEWave Life Sciences Ltd.LTM Mar 2026$183.34M USD+1.1%+13.2%255.4%
PRMEPrime Medicine, Inc.LTM Mar 2026$158.74M USD+42.5%+4.1%3935.1%
STOKStoke Therapeutics, Inc.LTM Mar 2026$147.7M USD-313.4%—460.4%
SLNSilence Therapeutics plcLTM Mar 2026$65.67M USD—+2.7%7126.6%
ARCTArcturus Therapeutics Holdings Inc.LTM Mar 2026$58.89M USD-34.5%—129.9%
PRQRProQR Therapeutics N.V.LTM Mar 2026€48.99M EUR+29.0%-9.3%364.5%
RNAAtrium Therapeutics, Inc.FY2025$42.57M USD——228.7%
BNTCBenitec Biopharma Inc.LTM Mar 2026$20.59M USD+10.2%+14.1%—
MGTXMeiraGTx Holdings plcLTM Mar 2026$2.34M USD-97.9%-24.8%2.9%
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —+1.1%+3.4%309.9%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.